Explaining the risks and benefits of recombinant tissue-plasminogen activator (rtPA) to eligible patients with acute ischemic stroke (AIS) within a few minutes is important but difficult.
Cheng-Yang Hsieh +6 more
doaj +1 more source
Characterizing plasmin-induced lag phase and application of PDMS microfluidics to detection of fibrinolytic activity [PDF]
Physical trauma is responsible for over six million deaths annually, and of these roughly 40 percent result from acute traumatic coagulopathy (ATC) occurring in the first few hours of incidence. Patients who have developed ATC have significantly improved
Ghani, Naveed
core
Recurrent Pregnancy Loss and Its Relation to FV Leiden, FII G20210A and Polymorphisms of Plasminogen Activator and Plasminogen Activator Inhibitor [PDF]
Cornelia Wolf +9 more
openalex +1 more source
SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer [PDF]
Pancreatic cancer has a devastating prognosis, with an overall 5-year survival rate of ~8%, restricted treatment options and characteristic molecular heterogeneity.
A H Allam +76 more
core +1 more source
Plasmin: indigenous milk proteinase
The most important characteristic of plasmin, as significant indigenous milk proteinase, its concentration, concentration measuring procedure and activity of plasmin are described.
Samir Kalit +2 more
doaj
Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis [PDF]
Joris J. T. H. Roelofs +7 more
openalex +1 more source
Doxycycline inhibits MMPs via modulation of plasminogen activators in focal cerebral ischemia
Tetracyclines inhibit matrix metalloproteinases (MMPs) and reduce infarction volume following cerebral ischemia. In this thesis an involvement of urokinase could be proven.
Dorothe Burggraf +3 more
doaj +1 more source
Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Is Not Associated with Neurological Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage [PDF]
Heikki Kiiski +6 more
openalex +1 more source
Functional Stability of Plasminogen Activator Inhibitor-1
Plasminogen activator inhibitor-1 (PAI-1) is the main inhibitor of plasminogen activators, such as tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA), and a major regulator of the fibrinolytic system.
Songul Yasar Yildiz +3 more
doaj +1 more source
As an essential thrombolytic agent, the tissue plasminogen activator receives increasing attention due to its longer half-life, lower immunogenicity, and easier administration, which are superior to other thrombolytic agents.
Tuo Song +6 more
doaj +1 more source

